Dr Peter Fellner
Appointed to the Board
14 November 2005. Chairman since May 2009
Dr Fellner is currently Chairman of Vernalis plc and Mereo Biopharma Group plc.
Peter is Chairman of the Nomination Committee.
Skills & Experience
Peter previously served as Chairman of Celltech Group plc from 2003 to July 2004, having been CEO from 1990 onwards. Before joining Celltech he was CEO of Roche UK from 1986 to 1990.
More recently he has been involved in a wide range of companies. These have included serving as Chairman of Ablynx nv from 2013 to 2018 and Optos plc from 2010 to 2015, until its acquisition by Nikon Corporation. He was also Chairman of Acambis plc from 2006, until its acquisition by Sanofi in 2008, and Chairman of Premier Research Group plc from 2007 to 2008, when it was acquired by a private-equity backed group. In addition, he was Vice Chairman of Astex Pharmaceuticals, Inc. from 2011 to 2013 when it was acquired by Otsuka. He was a Director of the global biopharmaceutical company UCB SA from 2005 to 2014, and also served as a Director of QinetiQ Group plc (2004-2009) and Evotec AG (2005-2011). He was a member of the Novo A/S Advisory Group from 2010 to 2016. He was a member of the Medical Research Council from 2000 to 2007.
In summary, Peter has many years’ experience in the pharmaceutical and biotechnology industry including senior R&D, executive and non-executive appointments.